X-101349693-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000061.3(BTK):​c.*192G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 442,227 control chromosomes in the GnomAD database, including 14,552 homozygotes. There are 35,609 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 5892 hom., 10233 hem., cov: 22)
Exomes 𝑓: 0.24 ( 8660 hom. 25376 hem. )

Consequence

BTK
NM_000061.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.493

Publications

7 publications found
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
BTK Gene-Disease associations (from GenCC):
  • Bruton-type agammaglobulinemia
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
  • isolated growth hormone deficiency type III
    Inheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BTKNM_000061.3 linkc.*192G>A 3_prime_UTR_variant Exon 19 of 19 ENST00000308731.8 NP_000052.1 Q06187-1Q5JY90
BTKNM_001287344.2 linkc.*192G>A 3_prime_UTR_variant Exon 19 of 19 NP_001274273.1 Q06187-2
BTKNM_001287345.2 linkc.*192G>A 3_prime_UTR_variant Exon 17 of 17 NP_001274274.1 Q06187Q5JY90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BTKENST00000308731.8 linkc.*192G>A 3_prime_UTR_variant Exon 19 of 19 1 NM_000061.3 ENSP00000308176.8 Q06187-1

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
35251
AN:
110320
Hom.:
5884
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.629
Gnomad AMI
AF:
0.0973
Gnomad AMR
AF:
0.349
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.439
Gnomad SAS
AF:
0.445
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.181
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.281
GnomAD4 exome
AF:
0.237
AC:
78600
AN:
331854
Hom.:
8660
Cov.:
4
AF XY:
0.245
AC XY:
25376
AN XY:
103512
show subpopulations
African (AFR)
AF:
0.630
AC:
6629
AN:
10515
American (AMR)
AF:
0.462
AC:
8245
AN:
17830
Ashkenazi Jewish (ASJ)
AF:
0.146
AC:
1411
AN:
9684
East Asian (EAS)
AF:
0.473
AC:
12047
AN:
25455
South Asian (SAS)
AF:
0.460
AC:
9643
AN:
20954
European-Finnish (FIN)
AF:
0.155
AC:
4427
AN:
28504
Middle Eastern (MID)
AF:
0.179
AC:
342
AN:
1915
European-Non Finnish (NFE)
AF:
0.158
AC:
31132
AN:
197450
Other (OTH)
AF:
0.242
AC:
4724
AN:
19547
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1750
3500
5249
6999
8749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.320
AC:
35298
AN:
110373
Hom.:
5892
Cov.:
22
AF XY:
0.313
AC XY:
10233
AN XY:
32671
show subpopulations
African (AFR)
AF:
0.629
AC:
18953
AN:
30133
American (AMR)
AF:
0.349
AC:
3590
AN:
10275
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
400
AN:
2646
East Asian (EAS)
AF:
0.439
AC:
1525
AN:
3475
South Asian (SAS)
AF:
0.444
AC:
1153
AN:
2596
European-Finnish (FIN)
AF:
0.154
AC:
900
AN:
5853
Middle Eastern (MID)
AF:
0.190
AC:
41
AN:
216
European-Non Finnish (NFE)
AF:
0.156
AC:
8242
AN:
52999
Other (OTH)
AF:
0.285
AC:
428
AN:
1502
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
704
1408
2113
2817
3521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.240
Hom.:
20845
Bravo
AF:
0.355

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked agammaglobulinemia with growth hormone deficiency Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

X-linked agammaglobulinemia Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.0
DANN
Benign
0.82
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057403; hg19: chrX-100604681; COSMIC: COSV58119536; COSMIC: COSV58119536; API